热门资讯> 正文
Rocket Pharmaceuticals Files Mixed-Shelf Offering
2024-08-17 05:00
05:00 PM EDT, 08/16/2024 (MT Newswires) -- Rocket Pharmaceuticals (RCKT) on Friday filed a registration statement with the US Securities and Exchange Commission for the potential sale of securities from time to time in one or more offerings.
The statement covers common and preferred shares, debt securities, warrants, and units, the filing showed.
The company plans to use the net proceeds for general corporate purposes.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
